INTEGER HOLDINGS CORPORATION Operating Lease, Right-of-Use Asset, Amortization Expense
INTEGER HOLDINGS CORPORATION (ITGR) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $4.88 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-04
- INTEGER HOLDINGS CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2026-07-03 was $2.42M, a 4.75% decline year-over-year.
- INTEGER HOLDINGS CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2026-04-03 was $2.45M, a 0.12% decline year-over-year.
- INTEGER HOLDINGS CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $2.58M, a 17.30% increase year-over-year.
- INTEGER HOLDINGS CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-26 was $2.58M, a 12.01% increase year-over-year.
- INTEGER HOLDINGS CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2025 was $10.16M, a 11.34% increase from fiscal 2024.
- INTEGER HOLDINGS CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2024 was $9.13M, a 18.87% decline from fiscal 2023.
- INTEGER HOLDINGS CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2023 was $11.25M, a 3.06% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2022 was $10.91M, a 32.53% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-07-03 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $4.88M 10-Q · filed 2026-08-04 | $7.45M derived: sum of 3 quarters · filed 2026-08-04 | $10.04M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-04-03 | $2.45M 10-Q · filed 2026-04-30 | $5.03M derived: sum of 2 quarters · filed 2026-04-30 | $7.61M derived: sum of 3 quarters · filed 2026-04-30 | $10.16M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $5.16M derived: sum of 2 quarters · filed 2026-02-23 | $7.71M derived: sum of 3 quarters · filed 2026-08-04 | $10.16M 10-K · filed 2026-02-23 |
| 2025-09-26 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $5.13M derived: sum of 2 quarters · filed 2026-08-04 | $7.58M 10-Q · filed 2025-10-23 | $9.78M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-27 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $5.00M 10-Q · filed 2026-08-04 | $7.20M derived: sum of 3 quarters · filed 2026-08-04 | $9.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-28 | $2.46M 10-Q · filed 2026-04-30 | $4.65M derived: sum of 2 quarters · filed 2026-04-30 | $6.96M derived: sum of 3 quarters · filed 2026-04-30 | $9.29M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $4.50M derived: sum of 2 quarters · filed 2026-02-23 | $6.83M derived: sum of 3 quarters · filed 2026-02-23 | $9.13M 10-K · filed 2026-02-23 |
| 2024-09-27 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $4.63M derived: sum of 2 quarters · filed 2025-10-23 | $6.93M 10-Q · filed 2025-10-23 | $10.05M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-28 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $4.62M 10-Q · filed 2025-07-24 | $7.75M derived: sum of 3 quarters · filed 2026-02-23 | $10.40M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-29 | $2.29M 10-Q · filed 2025-04-24 | $5.42M derived: sum of 2 quarters · filed 2026-02-23 | $8.07M derived: sum of 3 quarters · filed 2026-02-23 | $10.80M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $5.78M derived: sum of 2 quarters · filed 2026-02-23 | $8.51M derived: sum of 3 quarters · filed 2026-02-23 | $11.25M 10-K · filed 2026-02-23 |
| 2023-09-29 | $2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $5.38M derived: sum of 2 quarters · filed 2024-10-24 | $8.12M 10-Q · filed 2024-10-24 | $10.86M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $5.47M 10-Q · filed 2024-07-25 | $8.21M derived: sum of 3 quarters · filed 2025-02-20 | $11.04M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $2.74M 10-Q · filed 2024-04-25 | $5.48M derived: sum of 2 quarters · filed 2025-02-20 | $8.31M derived: sum of 3 quarters · filed 2025-02-20 | $11.12M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $5.57M derived: sum of 2 quarters · filed 2025-02-20 | $8.38M derived: sum of 3 quarters · filed 2025-02-20 | $10.91M 10-K · filed 2025-02-20 |
| 2022-09-30 | $2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $5.64M derived: sum of 2 quarters · filed 2023-10-26 | $8.18M 10-Q · filed 2023-10-26 | $10.50M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-07-01 | $2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $5.34M 10-Q · filed 2023-07-27 | $7.66M derived: sum of 3 quarters · filed 2024-02-20 | $9.63M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-04-01 | $2.54M 10-Q · filed 2023-04-27 | $4.86M derived: sum of 2 quarters · filed 2024-02-20 | $6.83M derived: sum of 3 quarters · filed 2024-02-20 | $8.77M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $4.29M derived: sum of 2 quarters · filed 2024-02-20 | $6.23M derived: sum of 3 quarters · filed 2024-02-20 | $8.23M 10-K · filed 2024-02-20 |
| 2021-10-01 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $3.91M derived: sum of 2 quarters · filed 2022-10-27 | $5.92M 10-Q · filed 2022-10-27 | |
| 2021-07-02 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $3.95M 10-Q · filed 2022-07-28 | ||
| 2021-04-02 | $2.00M 10-Q · filed 2022-04-28 | |||
| 2020-12-31 | $7.81M 10-K · filed 2023-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |